Most US peers are valued at multiples between 3-25 times BLT mkt cap
Somewhere in that range would be a good place to finish
Good HCV results you start to look at gilead etc with valuations in the billions (GILD mktcap >A$100bn)
Add to My Watchlist
What is My Watchlist?